Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021
Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …
[HTML][HTML] Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
IM Osmanov, E Spiridonova, P Bobkova… - European …, 2022 - Eur Respiratory Soc
Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …
remain poorly characterised. This study aimed to assess long-term outcomes in children …
[HTML][HTML] Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in …
…, DM Needham, P Glybochko, D Butnaru, IM Osmanov… - BMC medicine, 2022 - Springer
Background Previous studies assessing the prevalence of COVID-19 sequelae in adults
and children were performed in the absence of an agreed definition. We investigated …
and children were performed in the absence of an agreed definition. We investigated …
[HTML][HTML] A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …
[HTML][HTML] Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an …
…, SN Borzakova, AV Vlasova, IM Osmanov… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
[HTML][HTML] Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different …
…, MG Semple, JO Warner, P Olliaro, IM Osmanov… - BMC medicine, 2024 - Springer
Background Long-term health outcomes in children and young people (CYP) after COVID-19
infection are not well understood and studies with control groups exposed to other …
infection are not well understood and studies with control groups exposed to other …
[HTML][HTML] SARS-CoV-2 infection in children in Moscow in 2020: Clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children …
…, LN Mazankova, ER Samitova, IM Osmanov… - International Journal of …, 2022 - Elsevier
Objectives This study aimed to estimate the impact of the COVID-19 pandemic on the circulation
of non-SARS-CoV-2 respiratory viruses and the clinical characteristics of COVID-19 in …
of non-SARS-CoV-2 respiratory viruses and the clinical characteristics of COVID-19 in …
The problem of teenage tobacco smoking: yesterday, today, tomorrow
…, NA Geppe, IM Osmanov… - Pediatrics …, 2021 - pediatria.orscience.ru
The global prevalence of tobacco and nicotine-containing product use has now reached
epidemic proportions, a problem particularly relevant when it comes to adolescents. Major …
epidemic proportions, a problem particularly relevant when it comes to adolescents. Major …
Post-covid syndrome in children in rare cases of COVID-19
IN Zakharova, IM Osmanov… - Pediatrics …, 2022 - journals.eco-vector.com
Post-covid syndrome (PCS) is a symptom complex that occurs during and after COVID-19
lasting more than 12 weeks, which is not a possible disease. The clinical manifestations of …
lasting more than 12 weeks, which is not a possible disease. The clinical manifestations of …
Association of proteolysis factors with progression of autosomal dominant polycystic kidney disease in children
ZR Bashirova, IM Osmanov - Clinical nephrology, 2021 - pediatria.orscience.ru
Background. Autosomal dominant polycystic kidney disease (ADPKD) is the most common
hereditary kidney disease with an incidence of 1: 400 to 1: 1000, accounting for 7-10% of all …
hereditary kidney disease with an incidence of 1: 400 to 1: 1000, accounting for 7-10% of all …